Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3722 |  CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | 9.32 USD | -0.64% | +1.64% | +23.28% | -43.86% | 172.68 M USD | ||
| 3726 |  ORMP Oramed Pharmaceuticals Inc. - Common Stock | 4.31 USD | +0.23% | -5.48% | +17.76% | +95.91% | 176.39 M USD | ||
| 3732 |  PYXS Pyxis Oncology, Inc. - Common Stock | 2.76 USD | -10.10% | -6.12% | +64.29% | +144.25% | 174.86 M USD | ||
| 3739 |  IPHA Innate Pharma S.A. - American Depositary Shares | 1.85 USD | -2.63% | -0.54% | +5.11% | +5.71% | 173.38 M USD | ||
| 3742 |  PRQR ProQR Therapeutics N.V. - Ordinary Shares | 1.64 USD | -1.20% | -12.30% | +5.81% | -27.11% | 172.79 M USD | ||
| 3761 |  MOLN Molecular Partners AG - American Depositary Shares | 4.09 USD | +0.74% | +5.14% | +11.44% | +13.61% | 165.13 M USD | ||
| 3763 |  HUMA Humacyte, Inc. - Common Stock | 0.74 USD | -3.90% | 0.00% | -46.38% | -71.76% | 164.29 M USD | ||
| 3765 |  ADCT ADC Therapeutics SA Common Shares | 1.29 USD | -5.84% | +18.35% | +31.63% | -56.57% | 164.08 M USD | ||
| 3795 |  ANTX AN2 Therapeutics, Inc. - Common Stock | 4.36 USD | +1.40% | -12.63% | +14.44% | +315.24% | 157.03 M USD | ||
| 3809 |  TLSA Tiziana Life Sciences Ltd - Common Shares | 1.21 USD | -3.97% | -2.42% | 0.00% | -17.69% | 145.81 M USD | ||
| 3819 |  UNCY Unicycive Therapeutics, Inc. - Common Stock | 5.43 USD | 0.00% | +9.48% | -19.79% | -16.59% | 144.98 M USD | ||
| 3823 |  NRXP NRX Pharmaceuticals, Inc. - Common Stock | 3.90 USD | -6.25% | -2.50% | -10.14% | +119.10% | 141.29 M USD | ||
| 3824 |  MIST Milestone Pharmaceuticals Inc. - Common Shares | 1.20 USD | -6.98% | -10.45% | -3.23% | -47.14% | 149.40 M USD | ||
| 3829 |  IFRX InflaRx N.V. - Common Stock | 2.03 USD | -4.25% | -16.46% | +16.67% | +136.05% | 146.75 M USD | ||
| 3832 |  PEPG PepGen Inc. - Common Stock | 1.97 USD | -3.90% | +10.06% | +47.01% | +71.30% | 136.26 M USD | ||
| 3837 |  HURA TuHURA Biosciences, Inc. - Common Stock | 2.17 USD | -3.13% | -12.15% | +5.85% | -12.50% | 138.19 M USD | ||
| 3846 |  VTVT vTv Therapeutics Inc. - Class A Common Stock | 34.79 USD | +1.96% | -3.06% | +6.69% | +69.71% | 137.03 M USD | ||
| 3849 |  SPRB Spruce Biosciences, Inc. - Common Stock | 48.61 USD | -4.25% | -9.44% | -4.16% | +341.91% | 133.79 M USD | ||
| 3862 |  CNTB Connect Biopharma Holdings Limited - American Depositary Shares | 2.18 USD | -1.36% | -9.54% | -2.24% | +86.32% | 137.26 M USD | ||
| 3865 |  AGEN Agenus Inc. - Common Stock | 3.29 USD | -6.00% | +0.30% | +2.81% | -32.44% | 137.00 M USD |
Nouvelles Biotechnology Stocks
Un analyste voit un potentiel de vente de plusieurs milliards de dollars pour la thérapie phare de Zura Bio | Benzinga France
L'Immunome franchit une étape réglementaire clé alors que son médicament phare fait l'objet d'un examen par la FDA | Benzinga France
Seres Therapeutics publie des données préliminaires sur les complications de la thérapie contre le cancer | Benzinga France
TD Cowen réitère son avis d’achat sur Prime Medicine après une victoire en arbitrage
BofA maintient sa recommandation sur Beam Therapeutics après la décision arbitrale
Pourquoi l’action Beam Therapeutics chute-t-elle aujourd’hui ?
Pourquoi l’action Prime Medicine s’envole-t-elle aujourd’hui ?
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
 APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
 TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
 PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
 VANI Vivani Medical, Inc. - Common Stock | 1.50 | +11.11% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 CCCC C4 Therapeutics, Inc. - Common Stock | 3.81 | -12.41% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
 TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |